Survey of Ophthalmology
Volume 46, Issue 2 , Pages 117-142 , September 2001

von Hippel–Lindau Disease

References 

  1. Statement on use of DNA testing for presymptomatic identification of cancer risk. National Advisory Council for Human Genome Research. JAMA. 1994;271:785
  2. Alperin D. Massive exudative retinitis and angiomatosis retinae. Am J Ophthalmol. 1926;9:532–533
  3. Amoils SP, Smith TR. Cryotherapy of angiomatosis retinae. Arch Ophthalmol. 1969;81:689–691
  4. Annesley WJ, Leonard BC, Shields JA, Tasman WS. Fifteen year review of treated cases of retinal angiomatosis. Trans Am Acad Ophthalmol Otolaryngol. 1977;83:446–453
  5. Apple DJ, Goldberg MF, Wyhinny GJ. Argon laser treatment of von Hippel–Lindau retinal angiomas. II. Histopathology of treated lesions. Arch Ophthalmol. 1974;92:126–130
  6. Aprill BS, Drake AJ, Lasseter DH, Shakir KM. Silent adrenal nodules in von Hippel–Lindau disease suggest pheochromocytoma. Ann Intern Med. 1994;120:485–487
  7. Augsburger JJ, Shields JA, Goldberg RE. Classification and management of hereditary retinal angiomas. Int Ophthalmol. 1981;4:93–106
  8. Bailey P, Cushing H, Eisenhardt L. Angioblastic meningiomas. Arch Path. 1928;6:953–990
  9. Balazs E, Berta A, Rozsa L, et al.  Hemodynamic changes after ruthenium irradiation of Hippels angiomatosis. Ophthalmologica. 1990;200:128–132
  10. Balcer LJ, Galetta SL, Curtis M, et al.  von Hippel–Lindau disease manifesting as a chiasmal syndrome. Surv Ophthalmol. 1995;39:302–306
  11. Ballantyne AJ. Angiomatosis retinae. Account of a case including histologic results. Proc R Soc Med. 1941;35:345–358
  12. Barbazetto IA, Schmidt-Erfurth UM: Photodynamic therapy in the treatment of intraocular angioma[abstract]. Presented at the American Academy of Ophthalmology. Orlando, FL, USA, 1999
  13. Benjamin LE, Keshet E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors (induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal). Proc Natl Acad Sci USA. 1997;94:8761–8766
  14. Binkovitz LA, Johnson CD, Stephens DH. Islet cell tumors in von Hippel–Lindau disease (increased prevalence and relationship to the multiple endocrine neoplasias). AJR Am J Roentgenol. 1990;155:501–505
  15. Blodi CF, Russell SR, Pulido JS, Folk JC. Direct and feeder vessel photocoagulation of retinal angiomas with dye yellow laser. Ophthalmology. 1990;97:791–795discussion 796–7
  16. Bonnet M, Garmier G, Tlouzeau S, Burtin C: [Treatment of retinal capillary angiomas of von Hippels disease]. J Fr Ophtalmol 7:545–55, 1984
  17. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics, 1994. CA Cancer J Clin. 1994;44:7–26
  18. Brandt R. Zur Frage der Angiomatosis retinae. Von Graefes Arch Ophth. 1921;106:127–164
  19. Brauch H, Kishida T, Glavac D, et al.  von Hippel–Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany (evidence for a founder effect). Hum Genet. 1995;95:551–556
  20. Cardoso RD, Brockhurst RJ. Perforating diathermy coagulation for retinal angiomas. Arch Ophthalmol. 1976;94:1702–1715
  21. Carr RE, Noble KG. Retinal angiomatosis. Ophthalmology. 1980;87:956–959
  22. Chan CC, Vortmeyer AO, Chew EY, et al.  VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma. Arch Ophthalmol. 1999;117:625–630
  23. Chang JH, Spraul CW, Lynn ML, et al.  The two-stage mutation model in retinal hemangioblastoma. Ophthalmic Genet. 1998;19:123–130
  24. Chen F, Kishida T, Yao M, et al.  Germline mutations in the von Hippel–Lindau disease tumor suppressor gene (correlations with phenotype). Hum Mutat. 1995;5:66–75
  25. Cheng TY, Su CH, Shyr YM, Lui WY. Management of pancreatic lesions in von Hippel–Lindau disease. World J Surg. 1997;21:307–312
  26. Choyke PL, Glenn GM, Wagner JP, et al.  Epididymal cystadenomas in von Hippel–Lindau disease. Urology. 1997;49:926–931
  27. Choyke PL, Glenn GM, Walther MM, et al.  von Hippel–Lindau disease (genetic, clinical, and imaging features). Radiology. 1995;194:629–642
  28. Choyke PL, Glenn GM, Walther MM, et al.  The natural history of renal lesions in von Hippel–Lindau disease (a serial CT study in 28 patients). AJR Am J Roentgenol. 1992;159:1229–1234
  29. Coats G. Forms of retinal disease with massive exudation. Royal Lond Ophthal Hosp Rep. 1908;17:440–496
  30. Collins ET. Two cases, brother and sister, with peculiar vascular new growth probably primarily retinal, affecting both eyes. Trans Opthalmol Soc UK. 1894;14:141–149
  31. Cordes C, Hogan MJ. Angiomatosis retinae (Hippels disease) (report of a case in which roentgen therapy was used in an early stage). Arch Ophthalmol. 1940;23:253–269
  32. Cordes FC, Dickson OC. Angiomatosis retinae (von Hippels disease). Results following irradiation of three eyes. Am J Ophthalmol. 1943;26:454–463
  33. Cordes FC, Schwartz A. Angiomatosis retinae (von Hippels disease) eleven years after irradiation. Trans Am Ophthalmol Soc. 1943;50:227–235
  34. Craig WM, Wagener HP, Kernohan JW. Lindau-von Hippel disease (a report of four cases). Arch Neurol Psychiat. 1964;46:36–54
  35. Cushing H, Bailey P. Hemangioma of the cerebellum and retina (Lindaus disease) (with a report of a case). Arch Ophthalmol. 1928;57:182–200
  36. Czermak W. Pathologisch-anatomischer Befund bei der Von E. v. Hippel beschriebenen sehr seltenen Netzhauterkrankung. Ber Dtsch Ophthal Ges. 1906;32:184–195
  37. Darr JL, Hughes RP, McNair JN. Bilateral peripapillary retinal hemangiomas. A case report. Arch Ophthalmol. 1966;75:77–81
  38. Davison C, Brock S, Dyke CG. Retinal and central nervous hemangioblastomatosis with visceral changes (von Hippel–Lindau's disease). Bull Neurol Inst New York. 1936;5:72–93
  39. de Jong PT, Verkaart RJ, van de Vooren MJ, et al.  Twin vessels in von Hippel–Lindau disease. Am J Ophthalmol. 1988;105:165–169
  40. De Potter P, Shields CL, Shields JA. Tumors and pseudotumors of the retina. In:  De Potter P,  Shields JA,  Shields CL editor. MRI of the eye and orbit. Philadelphia: JB Lippincott Co; 1995;p. 121–125
  41. Ehlers N, Jensen OA. Juxtapapillary retinal hemangioblastoma (angiomatosis retinae) in an infant (light microscopical and ultrastructural examination). Ultrastruct Pathol. 1982;3:325–333
  42. Eldem B, Abbasoglu OE, Seber EC. Capillary hemangioma of the optic disc. Ann Ophthalmol. 1995;27:212–216
  43. Fill WL, Lamiell JM, Polk NO. The radiographic manifestations of von Hippel–Lindau disease. Radiology. 1979;133:289–295
  44. Filling-Katz MR, Choyke PL, Oldfield E, et al.  Central nervous system involvement in von Hippel–Lindau disease. Neurology. 1991;41:41–46
  45. Fuchs EF. Aneurysma arterio-venosum retinae. Arch Augenheilk. 1882;11:440–444
  46. Gaffey MJ, Mills SE, Boyd JC. Aggressive papillary tumor of middle ear/temporal bone and adnexal papillary cystadenoma. Manifestations of von Hippel–Lindau disease. Am J Surg Pathol. 1994;18:1254–1260
  47. Gardner KD, Evan AP. Cystic kidneys (an enigma evolves). Am J Kidney Dis. 1984;3:403–413
  48. Gass JD. Cavernous hemangioma of the retina. A neuro-oculo-cutaneous syndrome. Am J Ophthalmol. 1971;71:799–814
  49. Gass JD, Braunstein R. Sessile and exophytic capillary angiomas of the juxtapapillary retina and optic nerve head. Arch Ophthalmol. 1980;98:1790–1797
  50. Gass JDM. Treatment of retinal vascular anomalies. Trans Am Acad Ophthalmol Otolaryngol. 1977;83:432–442
  51. Geller G, Botkin JR, Green MJ, et al.  Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent. JAMA. 1997;277:1467–1474
  52. Ginzburg BM, Montanera WJ, Tyndel FJ, et al.  Diagnosis of von Hippel–Lindau disease in a patient with blindness resulting from bilateral optic nerve hemangioblastomas. AJR Am J Roentgenol. 1992;159:403–405
  53. Girelli R, Bassi C, Falconi M, et al.  Pancreatic cystic manifestations in von Hippel–Lindau disease. Int J Pancreatol. 1997;22:101–109
  54. Goes F, Benozzi J. Ultrasonography of haemangioma of the optic disc. Bull Soc Belge Ophtalmol. 1980;190:87–97
  55. Goldberg MF, Duke JR. von Hippel–Lindau disease. Histopathologic findings in a treated and an untreated eye. Am J Ophthalmol. 1968;66:693–705
  56. Goldberg MF, Koenig S. Argon laser treatment of von Hippel–Lindau retinal angiomas. I. Clinical and angiographic findings. Arch Ophthalmol. 1974;92:121–125
  57. Gorin MB. von Hippel–Lindau disease (clinical considerations and the use of fluorescein-potentiated argon laser therapy for treatment of retinal angiomas). Semin Ophthalmol. 1992;7:182–191
  58. Green JS, Bowmer MI, Johnson GJ. von Hippel–Lindau disease in a Newfoundland kindred. CMAJ. 1986;134:133–138
  59. Grossniklaus HE, Thomas JW, Vigneswaran N, Jarrett WH. Retinal hemangioblastoma. A histologic, immunohistochemical, and ultrastructural evaluation. Ophthalmology. 1992;99:140–145
  60. Haining WM, Zweifach PH. Fluorescein angiography in von Hippel–Lindau disease. Arch Ophthalmol. 1967;78:475–479
  61. Harbour JW. Tumor suppressor genes in ophthalmology. Surv Ophthalmol. 1999;44:235–246
  62. Hardwig P, Robertson DM. von Hippel–Lindau disease (a familial, often lethal, multi-system phakomatosis). Ophthalmology. 1984;91:263–270
  63. Hes FJ: von Hippel–Lindau disease: clinical and genetic investigations in the Netherlands. Utrecht, The Netherlands, Ponsen & Looijen BV, 2000, pp 29
  64. Horton WA, Wong V, Eldridge R. von Hippel–Lindau disease (clinical and pathological manifestations in nine families with 50 affected members). Arch Intern Med. 1976;136:769–777
  65. Hough DM, Stephens DH, Johnson CD, Binkovitz LA. Pancreatic lesions in von Hippel–Lindau disease (prevalence, clinical significance, and CT findings). AJR Am J Roentgenol. 1994;162:1091–1094
  66. Houwer AWM. von Hippels disease (retinal angiomatosis). Am J Ophthalmol. 1919;2:820
  67. Iliopoulos O, Kibel A, Gray S, Kaelin WG. Tumour suppression by the human von Hippel–Lindau gene product. Nat Med. 1995;1:822–826
  68. Ismail SM, Jasani B, Cole G. Histogenesis of haemangioblastomas (an immunocytochemical and ultrastructural study in a case of von Hippel–Lindau syndrome). J Clin Pathol. 1985;38:417–421
  69. Jackson JH. A series of cases illustrative of cerebral pathology. Case 1. Med Tms Gaz (Lond). 1872;11:544–549
  70. Jakobiec FA, Font RL, Johnson FB. Angiomatosis retinae. An ultrastructural study and lipid analysis. Cancer. 1976;38:2042–2056
  71. Jennings AM, Smith C, Cole DR, et al.  von Hippel–Lindau disease in a large British family (clinicopathological features and recommendations for screening and follow-up). QJM. 1988;66:233–249
  72. Jennings CM, Gaines PA. The abdominal manifestation of von Hippel–Lindau disease and a radiological screening protocol for an affected family. Clin Radiol. 1988;39:363–367
  73. Jesberg DO, Spencer WH, Hoyt WF. Incipient lesions of von Hippel–Lindau disease. Arch Ophthalmol. 1968;80:632–640
  74. Joe S, Spencer WH. von Hippel–Lindau disease. Arch Ophthalmol. 1964;71:508–509
  75. Johnson MW, Flynn HW, Gass JD. Pars plana vitrectomy and direct diathermy for complications of multiple retinal angiomas. Ophthalmic Surg. 1992;23:47–50
  76. Kaelin WG. Cancer. Many vessels, faulty gene. Nature. 1999;399:203–204
  77. Kaelin WG, Maher ER. The VHL tumour-suppressor gene paradigm. Trends Genet. 1998;14:423–426
  78. Karsdorp N, Elderson A, Wittebol-Post D, et al.  von Hippel–Lindau disease (new strategies in early detection and treatment). Am J Med. 1994;97:158–168
  79. Knudson AG. Mutation and cancer (statistical study of retinoblastoma). Proc Natl Acad Sci USA. 1971;68:820–823
  80. Korn WT, Schatzki SC, DiSciullo AJ, Scully RE. Papillary cystadenoma of the broad ligament in von Hippel–Lindau disease. Am J Obstet Gynecol. 1990;163:596–598
  81. Kragel PJ, Walther MM, Pestaner JP, Filling-Katz MR. Simple renal cysts, atypical renal cysts, and renal cell carcinoma in von Hippel–Lindau disease (a lectin and immunohistochemical study in six patients). Mod Pathol. 1991;4:210–214
  82. Kremer I, Gilad E, Ben-Sira I. Juxtapapillary exophytic retinal capillary hemangioma treated by yellow krypton (568 nm) laser photocoagulation. Ophthalmic Surg. 1988;19:743–747
  83. Kreusel KM, Bornfeld N, Lommatzsch A, et al.  Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma. Ophthalmology. 1998;105:1386–1392
  84. Laatikainen L, Immonen I, Summanen P. Peripheral retinal angiomalike lesion and macular pucker. Am J Ophthalmol. 1989;108:563–566
  85. Lamiell JM, Salazar FG, Hsia YE. von Hippel–Lindau disease affecting 43 members of a single kindred. Medicine (Baltimore). 1989;68:1–29
  86. Lamiell JM. VHL disease in history. Presented at the Second International VHL Symposium, Honolulu, Hawaii, June 17, 1996
  87. Lane CM, Turner G, Gregor ZJ, Bird AC. Laser treatment of retinal angiomatosis. Eye. 1989;3:33–38
  88. Latif F, Tory K, Gnarra J, et al.  Identification of the von Hippel–Lindau disease tumor suppressor gene. Science. 1993;260:1317–1320
  89. Lee JY, Dong SM, Park WS, et al.  Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. Cancer Res. 1998;58:504–508
  90. Lewis RA, Cohemn MH, Wise GN. Cavernous hemangioma of the retina and optic disc (a report of three cases and review of the literature). Br J Ophthalmol. 1975;59:422–434
  91. Libutti SK, Choyke PL, Bartlett DL, et al.  Pancreatic neuroendocrine tumors associated with von Hippel–Lindau disease (diagnostic and management recommendations). Surgery. 1998;124:1153–1159
  92. Lieb WE, Shields JA, Cohen SM, et al.  Color Doppler imaging in the management of intraocular tumors. Ophthalmology. 1990;97:1660–1664
  93. Lincoff H, McLean J, Long R. The cryosurgical treatment of intraocular tumors. Am J Ophthalmol. 1967;63:389–399
  94. Lindau A. Zur frage der angiomatosis retinae und ihrer hirnkomplikationen. Acta Ophthalmol. 1927;4:193–226
  95. Lindau A. Studien ber Kleinbirncysten Bau. Pathogenese und Beziehungen zur Angiomatosis Retinae. Acta Pathol Microbiol Scand. 1926;3(Suppl 1):1–28
  96. Lindau A, Sargent P, Collins ET. Discussion on vascular tumors of the brain and spinal cord. Proc Royal Soc Med. 1930;24:363–382
  97. Linehan WM, Lerman MI, Zbar B. Identification of the von Hippel–Lindau (VHL) gene. Its role in renal cancer. JAMA. 1995;273:564–570
  98. Lubensky IA, Gnarra JR, Bertheau P, et al.  Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel–Lindau disease patients. Am J Pathol. 1996;149:2089–2094
  99. Machemer R, Williams JM. Pathogenesis and therapy of traction detachment in various retinal vascular diseases. Am J Ophthalmol. 1988;105:170–181
  100. Macmichael IM. von Hippel Lindau disease of the optic disc. Trans Ophthalmol Soc UK. 1970;90:877–885
  101. Magnus H. Aneurysma arteriovenosum retinale. Virch Arch Path Anat. 1874;60:38–44
  102. Maher ER, Iselius L, Yates JR, et al.  von Hippel–Lindau disease (a genetic study). J Med Genet. 1991;28:443–447
  103. Maher ER, Kaelin WG. von Hippel–Lindau disease. Medicine (Baltimore). 1997;76:381–391
  104. Maher ER, Webster AR, Moore AT. Clinical features and molecular genetics of von Hippel–Lindau disease. Ophthalmic Genet. 1995;16:79–84
  105. Maher ER, Yates JR, Ferguson-Smith MA. Statistical analysis of the two stage mutation model in von Hippel–Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma. J Med Genet. 1990;27:311–314
  106. Maher ER, Yates JR, Harries R, et al.  Clinical features and natural history of von Hippel–Lindau disease. QJM. 1990;77:1151–1163
  107. Malek RS, Omess PJ, Benson RC, Zincke H. Renal cell carcinoma in von Hippel–Lindau syndrome. Am J Med. 1987;82:236–238
  108. Manski TJ, Heffner DK, Glenn GM, et al.  Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel–Lindau disease. JAMA. 1997;277:1461–1466
  109. Maxwell PH, Wiesener MS, Chang GW. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999;399:271–275
  110. McCabe CM, Flynn Jr, HW, Shields CL: Peripapillary capillary angiomas: Clinical features and visual acuity outcomes [abstract]. Presented at the American Academy of Ophthalmology. Orlando, 1999
  111. McGovern FH. Angiomatosis retinae. Am J Ophthalmol. 1943;26:184–187
  112. McGrath FP, Gibney RG, Morris DC, et al.  Case report (multiple hepatic and pulmonary haemangioblastomas—a new manifestation of von Hippel–Lindau disease). Clin Radiol. 1992;45:37–39
  113. Megerian CA, McKenna MJ, Nuss RC, et al.  Endolymphatic sac tumors (histopathologic confirmation, clinical characterization, and implication in von Hippel–Lindau disease). Laryngoscope. 1995;105:801–808
  114. Melmon KL, Rosen SW. Lindaus disease. Am J Med. 1964;36:595–617
  115. Meyer-Schwickerath G. The preservation of vision by treatment of intraocular tumors with light coagulation. Arch Ophthalmol. 1961;66:458–466
  116. Moller HU. Familial angiomatosis retinae et cerebelli. Acta Ophthalmol. 1929;7:244–260
  117. Moore AT, Maher ER, Rosen P, et al.  Ophthalmological screening for von Hippel–Lindau disease. Eye. 1991;5:723–728
  118. Moore RF. Choroidal sarcoma treated by intraocular insertion of radon seeds. Br J Ophthalmol. 1930;14:145–156
  119. Mottow-Lippa L, Tso MO, Peyman GA, Chejfec G. von Hippel angiomatosis. A light, electron microscopic, and immunoperoxidase characterization. Ophthalmology. 1983;90:848–855
  120. Neame H. Angiomatosis retinae, with report of pathological examination. Br J Ophthalmol. 1948;32:677–689
  121. Nerad JA, Kersten RC, Anderson RL. Hemangioblastoma of the optic nerve. Report of a case and review of literature. Ophthalmology. 1988;95:398–402
  122. Neumann HP. Basic criteria for clinical diagnosis and genetic counselling in von Hippel–Lindau syndrome. Vasa. 1987;16:220–226
  123. Neumann HP, Bender BU, Reincke M, et al.  Adrenal-sparing surgery for phaeochromocytoma. Br J Surg. 1999;86:94–97
  124. Neumann HP, Berger DP, Sigmund G, et al.  Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel–Lindau disease. N Engl J Med. 1993;329:1531–1538
  125. Neumann HP, Dinkel E, Brambs H, et al.  Pancreatic lesions in the von Hippel–Lindau syndrome. Gastroenterology. 1991;101:465–471
  126. Neumann HP, Eggert HR, Weigel K, et al.  Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel–Lindau syndrome. J Neurosurg. 1989;70:24–30
  127. Neumann HP, Eng C, Mulligan LM, et al.  Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II. JAMA. 1995;274:1149–1151
  128. Neumann HP, Wiestler OD. Clustering of features of von Hippel–Lindau syndrome (evidence for a complex genetic locus). Lancet. 1991;337:1052–1054
  129. Nicholson DH. Induced ocular hypertension during photocoagulation of afferent artery in angiomatosis retinae. Retina. 1983;3:59–61
  130. Nicholson DH, Green WR, Kenyon KR. Light and electron microscopic study of early lesions in angiomatosis retinae. Am J Ophthalmol. 1976;82:193–204
  131. Niemela M, Lemeta S, Sainio M, et al.  Hemangioblastomas of the retina (impact of von Hippel–Lindau disease). Invest Ophthalmol Vis Sci. 2000;41:1909–1915
  132. Oosterhuis JA, Journee-de Korver HG, Kakebeeke-Kemme HM, Bleeker JC. Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol. 1995;113:315–321
  133. Oosterhuis JA, Rubinstein K. Haemangioma at the optic disc. Ophthalmologica. 1972;164:362–374
  134. Othmane IS, Shields C, Singh A, et al.  Postpartum cerebellar herniation in von Hippel–Lindau syndrome. Am J Ophthalmol. 1999;128:387–389
  135. Othmane IS, Shields CL, Shields JA, et al.  Circumscribed choroidal hemangioma managed by transpupillary thermotherapy. Arch Ophthalmol. 1999;117:136–137
  136. Palmer JD, Gragoudas ES. Advances in treatment of retinal angiomas. Int Ophthalmol Clin. 1997;37:150–170
  137. Peyman GA, Raichand M, Zeimer RC. Ocular effects of various laser wavelengths. Surv Ophthalmol. 1984;28:391–404
  138. Peyman GA, Rednam KR, Mottow-Lippa L, Flood T. Treatment of large von Hippel tumors by eye wall resection. Ophthalmology. 1983;90:840–847
  139. Ponder BAJ. Inherited cancer syndromes. In:  Carney Sikora K editors. Genes and cancer. New York: John Wiley and Sons Ltd; 1990;p. 99–106
  140. Probst A, Lotz M, Heitz P. von Hippel–Lindaus Disease, syringomyelia and multiple endocrine tumors (a complex neuroendocrinopathy). Virchows Arch A Pathol Anat Histol. 1978;378:265–272
  141. Pye-Smith PH. Cysts of cerebellum with numerous small cysts in the pancreas and kidneys. Transac Pathol Soc London. 1885;36:17–21
  142. Rabb MF, Gagliano DA, Teske MP. Retinal arterial macroaneurysms. Surv Ophthalmol. 1988;33:73–96
  143. Reich H, Hollwich F: [von Hippel–Lindau syndrome]. Klin Monatsbl Augenheilkd 184:513–9, 1984
  144. Renbaum P, Duh FM, Latif F, et al.  Isolation and characterization of the full-length 3 untranslated region of the human von Hippel–Lindau tumor suppressor gene. Hum Genet. 1996;98:666–671
  145. Richard S, Campello C, Taillandier L, et al.  Haemangioblastoma of the central nervous system in von Hippel–Lindau disease. French VHL Study Group. J Intern Med. 1998;243:547–553
  146. Richard S, Chauveau D, Chretien Y, et al.  Renal lesions and pheochromocytoma in von Hippel–Lindau disease. Adv Nephrol Necker Hosp. 1994;23:1–27
  147. Richards FM, Payne SJ, Zbar B, et al.  Molecular analysis of de novo germline mutations in the von Hippel–Lindau disease gene. Hum Mol Genet. 1995;4:2139–2143
  148. Ridley M, Green J, Johnson G. Retinal angiomatosis (the ocular manifestations of von Hippel–Lindau disease). Can J Ophthalmol. 1986;21:276–283
  149. Ridley ME, Shields JA, Brown GC, Tasman W. Coats disease. Evaluation of management. Ophthalmology. 1982;89:1381–1387
  150. Rohrschneider K, Burk RO, Bornfeld N, Volcker HE: [Capillary hemangioma of the retina. Laser scanning tomography follow- up after radiotherapy]. Fortschr Ophthalmol 88:623–8, 1991
  151. Rosa RH, Goldberg MF, Green WR. Clinicopathologic correlation of argon laser photocoagulation of retinal angiomas in a patient with von Hippel–Lindau disease followed for more than 20 years. Retina. 1996;16:145–156
  152. Sakashita N, Takeya M, Kishida T, et al.  Expression of von Hippel–Lindau protein in normal and pathological human tissues. Histochem J. 1999;31:133–144
  153. Salazar FG, Lamiell JM. Early identification of retinal angiomas in a large kindred von Hippel–Lindau disease. Am J Ophthalmol. 1980;89:540–545
  154. Sato Y, Waziri M, Smith W, et al.  Hippel–Lindau disease (MR imaging). Radiology. 1988;166:241–246
  155. Schindler RF, Sarin LK, MacDonald PR. Hemangiomas of the optic disc. Can J Ophthalmol. 1975;10:305–318
  156. Schmidt D, Natt E, Neumann HP. Long-term results of laser treatment for retinal angiomatosis in von Hippel–Lindau disease. Eur J Med Res. 2000;5:47–58
  157. Schmidt D, Neumann HP. Retinal vascular hamartoma in von Hippel–Lindau disease. Arch Ophthalmol. 1995;113:1163–1167
  158. Schoenfeld A, Davidowitz EJ, Burk RD. A second major native von Hippel–Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor. Proc Natl Acad Sci USA. 1998;95:8817–8822
  159. Schwartz PL, Fastenberg DM, Shakin JL. Management of macular puckers associated with retinal angiomas. Ophthalmic Surg. 1990;21:550–556
  160. Sellors PJH. The management of retinal angiomatosis. Trans Ophthalmol Soc U K. 1969;89:529–543
  161. Sgambati MT, Stolle C, Choyke PL, et al.  Mosaicism in von Hippel–Lindau disease (lessons from kindreds with germline mutations identified in offspring with mosaic parents). Am J Hum Genet. 2000;66:84–91
  162. Shields CL, Santos MC, Diniz W, et al.  Thermotherapy for retinoblastoma. Arch Ophthalmol. 1999;117:885–893
  163. Shields CL, Shields JA, Barrett J, De Potter P. Vasoproliferative tumors of the ocular fundus. Classification and clinical manifestations in. 1995;103(patients. Arch Ophthalmol 113):615–623
  164. Shields CL, Shields JA, Cater J, et al.  Transpupillary thermotherapy for choroidal melanoma (tumor control and visual results in 100 consecutive cases). Ophthalmology. 1998;105:581–590
  165. Shields CL, Shields JA, De Potter P. Patterns of indocyanine green videoangiography of choroidal tumours. Br J Ophthalmol. 1995;79:237–245
  166. Shields JA. Response of retinal capillary hemangioma to cryotherapy. Arch Ophthalmol. 1993;111:551
  167. Shields JA, Decker WL, Sanborn GE, et al.  Presumed acquired retinal hemangiomas. Ophthalmology. 1983;90:1292–1300
  168. Shields JA, Joffe L, Guibor P. Choroidal melanoma clinically simulating a retinal angioma. Am J Ophthalmol. 1978;85:67–71
  169. Shields JA, Shields CL. In: A text and atlas. Philadelphia: WB Saunders Co; 1992;p. 394–398
  170. Shields JA, Shields CL. In: Atlas of intraocular tumors. Philadelphia: Lippincott Williams and Wilkins; 1999;p. 261
  171. Shields JA, Shields CL, Gunduz K, Eagle RC. Neoplasms of the retinal pigment epithelium (the 1998 Albert Ruedemann, Sr, memorial lecture, Part 2). Arch Ophthalmol. 1999;117:601–608
  172. Sigelman J. In: Retinal diseases. Pathogenesis, laser therapy and surgery. Boston: Little, Brown and Company; 1984;p. 316
  173. Singh AD, Shields JA, Shields CL. Solitary retinal capillary hemangioma (hereditary (von Hippel–Lindau disease) or non hereditary?). Arch Ophthalmol. 2001;119:232–234
  174. Stallard HB. Radiotherapy for malignant melanoma of the choroid. Br J Ophthalmol. 1966;50:147–155
  175. Stallard HB. Radiant energy as a pathogenic and a therapeutic agent in ophthalmic disorders. Br J Opthalmol. 1933;6(Suppl):1–79
  176. Stolle C, Glenn G, Zbar B, et al.  Improved detection of germline mutations in the von Hippel–Lindau disease tumor suppressor gene. Hum Mutat. 1998;12:417–423
  177. Straatsma BR. Angiomatosis retinae. N Engl J Med. 1954;250:314–317
  178. Sung DI, Chang CH, Harisiadis L. Cerebellar hemangioblastomas. Cancer. 1982;49:553–555
  179. Takahashi T, Wada H, Tani E, et al.  Capillary hemangioma of the optic disc. J Clin Neuroophthalmol. 1984;4:159–162
  180. Usher CH. On a few hereditary eye affections. Trans Ophthalmol Soc UK. 1935;55:164–245
  181. Vail D. Angiomatosis retinae, eleven years after diathermy coagulation. Am J Ophthalmol. 1958;46:525–534
  182. von Hippel E. Noch einmal zur angiomatosis retinae. Graefes Arch Ophthalmol. 1927;118:348–358
  183. von Hippel E. Uber eine sehr self seltene Erkrankung der Netzhaut. Graefes Arch Ophthalmol. 1904;59:83–106
  184. Vortmeyer AO, Chan CC, Chew EY, et al.  Morphologic and genetic analysis of retinal angioma associated with massive gliosis in a patient with von Hippel–Lindau disease. Graefes Arch Clin Exp Ophthalmol. 1999;237:513–517
  185. Walther MM, Reiter R, Keiser HR, et al.  Clinical and genetic characterization of pheochromocytoma in von Hippel–Lindau families (comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma). J Urol. 1999;162:659–664
  186. Watzke RC. Cryotherapy for retinal angiomatosis. A clinicopathologic report. Arch Ophthalmol. 1974;92:399–401
  187. Webster AR, Maher ER, Bird AC, et al.  A clinical and molecular genetic analysis of solitary ocular angioma. Ophthalmology. 1999;106:623–629
  188. Webster AR, Maher ER, Bird AC, Moore AT. Risk of multisystem disease in isolated ocular angioma (haemangioblastoma). J Med Genet. 2000;37:62–63
  189. Webster AR, Maher ER, Moore AT. Clinical characteristics of ocular angiomatosis in von Hippel–Lindau disease and correlation with germline mutation. Arch Ophthalmol. 1999;117:371–378
  190. Webster AR, Richards FM, MacRonald FE, et al.  An analysis of phenotypic variation in the familial cancer syndrome von Hippel–Lindau disease (evidence for modifier effects). Am J Hum Genet. 1998;63:1025–1035
  191. Weitzel JN. Genetic cancer risk assessment. Putting it all together. Cancer. 1999;86:1663–1672
  192. Welch RB. Fluorescein angiography in sickle-cell retinopathy and von Hippel–Lindau disease. Int Ophthalmol Clin. 1977;17:137–154
  193. Welch RB. von Hippel–Lindau disease (the recognition and treatment of early angiomatosis retinae and the use of cryosurgery as an adjunct to therapy). Trans Am Ophthalmol Soc. 1970;68:367–424
  194. Weve H. On diathermy in ophthalmic practice. Trans Ophthalmol Soc UK. 1939;59:43–80
  195. Whitson JT, Welch RB, Green WR. von Hippel–Lindau disease (case report of a patient with spontaneous regression of a retinal angioma). Retina. 1986;6:253–259
  196. Wing GL, Weiter JJ, Kelly PJ, et al.  von Hippel–Lindau disease (angiomatosis of the retina and central nervous system). Ophthalmology. 1981;88:1311–1314
  197. Wittebol-Post D, Hes FJ, Lips CJ. The eye in von Hippel–Lindau disease. Long-term follow-up of screening and treatment (recommendations). J Intern Med. 1998;243:555–561
  198. Witten FR, OBrien DP, Sewell CW, Wheatley JK. Bilateral clear cell papillary cystadenoma of the epididymides presenting as infertility (an early manifestation of von Hippel–Lindaus syndrome). J Urol. 1985;133:1062–1064
  199. Wizigmann-Voos S, Plate KH. Pathology, genetics and cell biology of hemangioblastomas. Histol Histopathol. 1996;11:1049–1061
  200. Wood DJ. Retinal detachment with unusual dilation of retinal vessels and other changes. Trans Ophthalmol Soc UK. 1892;12:143
  201. Ye Y, Vasavada S, Kuzmin I, et al.  Subcellular localization of the von Hippel–Lindau disease gene product is cell cycle-dependent. Int J Cancer. 1998;78:62–69
  202. Yimoyines DJ, Topilow HW, Abedin S, McMeel JW. Bilateral peripapillary exophytic retinal hemangioblastomas. Ophthalmology. 1982;89:1388–1392
  203. Zbar B, Brauch H, Talmadge C, Linehan M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature. 1987;327:721–724
  204. Zbar B, Kaelin W, Maher E, Richard S. Third international meeting on von Hippel–Lindau disease. Cancer Res. 1999;59:2251–2253
  205. Zbar BH, Kishida T, Chen F. Germline mutations in the von Hippel–Lindau diseases (VHL) gene in families from North America, Europe and Japan. Hum Mutation. 1996;8:348–357

☆ The authors have no commercial or proprietary interest in any product or concept discussed in this article.

PII: S0039-6257(01)00245-4

Survey of Ophthalmology
Volume 46, Issue 2 , Pages 117-142 , September 2001

Article Tools

* Image Usage & Resolution